Clinical Trials Browser

Disease, Melanoma

NCT04186845 2025-09-22

Spotlight

Phase 3 Completed

391 enrolled 30 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT04410133 2025-08-28

REVELATE

Phase 3 Completed

151 enrolled 29 charts

CNS

Brain Neoplasms, Disease

NCT05578872 2025-08-26

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

Phase 1/2 Completed

29 enrolled 15 charts

Dermatologic

Disease, Melanoma, Neoplasm Metastasis, Neoplasms

NCT04410367 2025-07-20

PURSUE

Phase 2 Completed

23 enrolled 10 charts

CNS

Brain Neoplasms, Disease

NCT04186819 2025-02-26

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

Phase 3 Completed

356 enrolled 28 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT02981368 2021-08-09

OSPREY

Phase 2/3 Completed

385 enrolled 20 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT03739684 2021-06-14

CONDOR

Phase 3 Completed

208 enrolled 10 charts

Genitourinary

Disease, Prostatic Neoplasms

NCT01373671 2020-08-07

DBT

Phase NA Completed

764 enrolled 5 charts

Breast

Breast Neoplasms, Disease

NCT00894127 2019-10-30

Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Phase 1/2 Completed

128 enrolled 4 charts

Thoracic

Disease, Lung Neoplasms

NCT01566682 2019-09-04

A Multi-Center Trial of the ProLung Test™

Completed

420 enrolled 5 charts

Thoracic

Solitary Pulmonary Nodule, Disease, Lung Neoplasms, Multiple Pulmonary Nodules

NCT00788892 2018-01-12

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

Phase 2 Completed

126 enrolled 12 charts

Other hematologic neoplasm

Disease, Leukemia, Leukemia, Myeloid, Acute

NCT02540850 2016-01-11

RESEPT

Completed

1,031 enrolled 13 charts

Gastrointestinal

Adenoma, Disease, Polyps, Wounds and Injuries, Colorectal Neoplasms

NCT02388074 2015-07-14

Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Phase NA Completed

25 enrolled 3 charts

Thoracic

Disease, Lung Neoplasms

NCT00284141 2012-12-10

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma

Phase 2 Completed

98 enrolled 14 charts

Thoracic

Carcinoma, Carcinoma, Non-Small-Cell Lung, Disease, Lung Diseases, Lung Neoplasms, Neoplasm Metastasis, Neoplasms

Clinical Trials

LEGIT_MC_EVCDA

Spotlight

REVELATE

A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).

PURSUE

Imaging Study to Investigate the Safety and Diagnostic Performance of rhPSMA 7.3 (18F) in Newly Diagnosed Prostate Cancer.

OSPREY

CONDOR

DBT

Sputum Labeling Utilizing Synthetic Meso Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

A Multi-Center Trial of the ProLung Test™

Trial of CPX-351 in Newly Diagnosed Elderly AML Patients

RESEPT

Sputum Labeling Utilizing Synthetic Meso-Tetra (4-Carboxyphenyl) Porphine (TCPP) for Detection of Lung Cancer

Study of AVE0005 (VEGF Trap) in Locally Advanced or Metastatic Platinum- and Erlotinib- Resistant Non-small-cell-lung Adenocarcinoma